One of the key steps in human carcinogenesis is the activation of a telomere maintenance system that allows the continued proliferation of transformed cells. The telomeres of primary human cells shorten with each cell division and this attrition eventually induces cell cycle arrest, thus limiting the proliferative capacity of emerging tumorigenic clones. Malignant cells are known to overcome this barrier through the activation of telomerase, the RNP reverse transcriptase that synthesizes telomeric DNA onto chromosome ends. In the preceding funding period, we have described a regulatory pathway in cancer cells that controls the action of telomerase at individual chromosome ends. This telomere length regulation depends on the telomere specific protein complex, shelterin, which acts in cis to inhibit telomerase. Shelterin's accumulation at telomeres is proportional to the length of the telomeric repeat array, resulting in a greater inhibition of telomerase at longer telomeres. In the next funding period, we will further define the mechanism of telomerase inhibition by shelterin (AIM 1). The work in AIM 2 will focus on the positive regulation of telomerase-mediated telomere extension in human tumor cell lines. Whereas the expression of telomerase components and the biogenesis of the enzyme has been analyzed in detail, little is known about how telomerase is recruited to chromosome ends, how this recruitment is regulated, and whether telomerase requires additional activation steps. Our preliminary data has revealed putative positive regulators of telomerase-mediated telomere elongation and we propose to define these pathways and others like it further. In a second new direction, we will focus on the mechanism and regulation of telomere shortening (AIM 3), which is poorly understood, despite its importance as a presumed tumor suppressor pathway. The attrition of human telomeres is much faster than expected from the `end-replication problem'but the process underlying this accelerated terminal sequence loss is not known. Our preliminary data suggests that telomere attrition involves shelterin regulated degradation of the C-rich telomeric DNA strand. We propose to identify the genes responsible for telomere shortening in (pre-) malignant cells and study the regulation of this processing step. It is anticipated that insights into the molecular basis of telomere length control will provide opportunities for therapeutic intervention in a wide variety of human cancers, including leukemias, lymphomas, and most carcinomas.

Public Health Relevance

Normal human cells gradually lose the DNA at the end of their chromosomes with each cell division. Cancer cells achieve immortal growth by replenishing this terminal DNA. We propose to study the mechanism of terminal sequence loss and determine how cancer cells counteract this process in the anticipation that our insights will provide new avenues for the treatment, diagnosis, and prevention of human cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA076027-12
Application #
7737361
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Pelroy, Richard
Project Start
1997-12-15
Project End
2012-11-30
Budget Start
2009-12-01
Budget End
2010-11-30
Support Year
12
Fiscal Year
2010
Total Cost
Indirect Cost
Name
Ohio State University
Department
Anatomy/Cell Biology
Type
Graduate Schools
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Lovejoy, Courtney A; Li, Wendi; Reisenweber, Steven et al. (2012) Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 8:e1002772
Sfeir, Agnel; de Lange, Titia (2012) Removal of shelterin reveals the telomere end-protection problem. Science 336:593-7
Wu, Peng; Takai, Hiroyuki; de Lange, Titia (2012) Telomeric 3' overhangs derive from resection by Exo1 and Apollo and fill-in by POT1b-associated CST. Cell 150:39-52
Davoli, Teresa; de Lange, Titia (2011) The causes and consequences of polyploidy in normal development and cancer. Annu Rev Cell Dev Biol 27:585-610
Wu, Peng; van Overbeek, Megan; Rooney, Sean et al. (2010) Apollo contributes to G overhang maintenance and protects leading-end telomeres. Mol Cell 39:606-17
de Lange, T (2010) How shelterin solves the telomere end-protection problem. Cold Spring Harb Symp Quant Biol 75:167-77
Takai, Kaori K; Hooper, Sarah; Blackwood, Stephanie et al. (2010) In vivo stoichiometry of shelterin components. J Biol Chem 285:1457-67
Kabir, Shaheen; Sfeir, Agnel; de Lange, Titia (2010) Taking apart Rap1: an adaptor protein with telomeric and non-telomeric functions. Cell Cycle 9:4061-7
Sfeir, Agnel; Kosiyatrakul, Settapong T; Hockemeyer, Dirk et al. (2009) Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138:90-103
de Lange, Titia (2009) How telomeres solve the end-protection problem. Science 326:948-52

Showing the most recent 10 out of 32 publications